Pierre A. Morgon is Chief Marketing Officer and member of the Executive Committee at Cegedim. He is also Non-Executive Director to the Board of Theradiag since March 2012, a company focusing on in vitro diagnostics in auto-immunity, infectious diseases and allergy, as well as Non-Executive Director to the Board of Eurocine Vaccines since December 2013, a company dedicated to developing nasal vaccines.He holds a Doctorate of Pharmacy from Lyon University, France, a Master in Business Law from the Lyon Law School and a MBA from ESSEC, France. He is also an alumnus of INSEAD, IMD and MCE executive programs.Pierre has over 26 years of experience in the pharmaceutical and biological industry, both in marketing positions (from product marketing at country level to global marketing strategy) and in operations (from business unit head to general manager).  Through these local and global positions, he has acquired direct experience with blockbuster products in diverse markets (primary care, specialty care, hospital, vaccines, and biotechnology), geographies (US, Europe, Japan, China, India, Emerging Markets) and organizations.He spent 2 years at ICI-Pharma, followed by 8 years at Synthelabo, then a division of L’Oreal. He joined Aventis Pasteur in 1998, then he had diversified experiences in operations at Yamanouchi Pharma, BMS, Drug Abuse Sciences, Schering-Plough and Bio Alliance Pharma. He joined Cegedim from Sanofi Pasteur where he was Vice President, Franchise & Global Marketing Strategy and member of the Executive Committee.

• Ch 1 Sustainable development for the healthcare industry: Setting the stage.- Ch 2 Can innovation still be the main growth driver of the pharmaceutical industry?.- Ch 3 The importance of understanding the 'lived experience' of patients in pharmaceutical development programs.- Ch 4 Listening to the voice of the patient to facilitate earlier access to promising medicines: Interview with Sjaak Vink.- Ch 5 Drivers of the Real World Data revolution and the transition to Adaptive Licensing: Interview with Dr. Richard Barker.- Ch 6 Sustainable development for the healthcare industry: Vantage Point from Emerging Economies.- Ch 7 Disease Management in the perspective of sustainable growth in heath care system.- Ch 8 Thoughts on Sustainable Healthcare...in a Patient-Centric Society.- Ch 9 The Biopharmaceutical Industry as part of the solution for healthier, wealthier societies: Interview with Dr. Eduardo Pisani.- Ch 10 Sustainable development initiatives: Examples of successful programs and lessons learned-Interview with Dr. François Bompart.- Ch 11 The challenges of Sustainable Development for the Healthcare Industry: An Examination from the Perspectives of Biomedical Enterprises.- Ch 12 Corporation's social responsibility: From the awareness of philanthropy to the demand of implementation-The Case of Expanscience.

Pierre A. Morgon is Chief Marketing Officer and member of the Executive Committee at Cegedim. He is also Non-Executive Director to the Board of Theradiag since March 2012, a company focusing on in vitro diagnostics in auto-immunity, infectious diseases and allergy, as well as Non-Executive Director to the Board of Eurocine Vaccines since December 2013, a company dedicated to developing nasal vaccines.He holds a Doctorate of Pharmacy from Lyon University, France, a Master in Business Law from the Lyon Law School and a MBA from ESSEC, France. He is also an alumnus of INSEAD, IMD and MCE executive programs.Pierre has over 26 years of experience in the pharmaceutical and biological industry, both in marketing positions (from product marketing at country level to global marketing strategy) and in operations (from business unit head to general manager).  Through these local and global positions, he has acquired direct experience with blockbuster products in diverse markets (primary care, specialty care, hospital, vaccines, and biotechnology), geographies (US, Europe, Japan, China, India, Emerging Markets) and organizations.He spent 2 years at ICI-Pharma, followed by 8 years at Synthelabo, then a division of L’Oreal. He joined Aventis Pasteur in 1998, then he had diversified experiences in operations at Yamanouchi Pharma, BMS, Drug Abuse Sciences, Schering-Plough and Bio Alliance Pharma. He joined Cegedim from Sanofi Pasteur where he was Vice President, Franchise & Global Marketing Strategy and member of the Executive Committee.

• Ch 1 Sustainable development for the healthcare industry: Setting the stage.- Ch 2 Can innovation still be the main growth driver of the pharmaceutical industry?.- Ch 3 The importance of understanding the 'lived experience' of patients in pharmaceutical development programs.- Ch 4 Listening to the voice of the patient to facilitate earlier access to promising medicines: Interview with Sjaak Vink.- Ch 5 Drivers of the Real World Data revolution and the transition to Adaptive Licensing: Interview with Dr. Richard Barker.- Ch 6 Sustainable development for the healthcare industry: Vantage Point from Emerging Economies.- Ch 7 Disease Management in the perspective of sustainable growth in heath care system.- Ch 8 Thoughts on Sustainable Healthcare...in a Patient-Centric Society.- Ch 9 The Biopharmaceutical Industry as part of the solution for healthier, wealthier societies: Interview with Dr. Eduardo Pisani.- Ch 10 Sustainable development initiatives: Examples of successful programs and lessons learned-Interview with Dr. François Bompart.- Ch 11 The challenges of Sustainable Development for the Healthcare Industry: An Examination from the Perspectives of Biomedical Enterprises.- Ch 12 Corporation's social responsibility: From the awareness of philanthropy to the demand of implementation-The Case of Expanscience.

Pierre A. Morgon is Chief Marketing Officer and member of the Executive Committee at Cegedim. He is also Non-Executive Director to the Board of Theradiag since March 2012, a company focusing on in vitro diagnostics in auto-immunity, infectious diseases and allergy, as well as Non-Executive Director to the Board of Eurocine Vaccines since December 2013, a company dedicated to developing nasal vaccines.He holds a Doctorate of Pharmacy from Lyon University, France, a Master in Business Law from the Lyon Law School and a MBA from ESSEC, France. He is also an alumnus of INSEAD, IMD and MCE executive programs.Pierre has over 26 years of experience in the pharmaceutical and biological industry, both in marketing positions (from product marketing at country level to global marketing strategy) and in operations (from business unit head to general manager).  Through these local and global positions, he has acquired direct experience with blockbuster products in diverse markets (primary care, specialty care, hospital, vaccines, and biotechnology), geographies (US, Europe, Japan, China, India, Emerging Markets) and organizations.He spent 2 years at ICI-Pharma, followed by 8 years at Synthelabo, then a division of L’Oreal. He joined Aventis Pasteur in 1998, then he had diversified experiences in operations at Yamanouchi Pharma, BMS, Drug Abuse Sciences, Schering-Plough and Bio Alliance Pharma. He joined Cegedim from Sanofi Pasteur where he was Vice President, Franchise & Global Marketing Strategy and member of the Executive Committee.

• Ch 1 Sustainable development for the healthcare industry: Setting the stage.- Ch 2 Can innovation still be the main growth driver of the pharmaceutical industry?.- Ch 3 The importance of understanding the 'lived experience' of patients in pharmaceutical development programs.- Ch 4 Listening to the voice of the patient to facilitate earlier access to promising medicines: Interview with Sjaak Vink.- Ch 5 Drivers of the Real World Data revolution and the transition to Adaptive Licensing: Interview with Dr. Richard Barker.- Ch 6 Sustainable development for the healthcare industry: Vantage Point from Emerging Economies.- Ch 7 Disease Management in the perspective of sustainable growth in heath care system.- Ch 8 Thoughts on Sustainable Healthcare...in a Patient-Centric Society.- Ch 9 The Biopharmaceutical Industry as part of the solution for healthier, wealthier societies: Interview with Dr. Eduardo Pisani.- Ch 10 Sustainable development initiatives: Examples of successful programs and lessons learned-Interview with Dr. François Bompart.- Ch 11 The challenges of Sustainable Development for the Healthcare Industry: An Examination from the Perspectives of Biomedical Enterprises.- Ch 12 Corporation's social responsibility: From the awareness of philanthropy to the demand of implementation-The Case of Expanscience.